BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27568332)

  • 21. Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.
    Deb S; Wong SQ; Li J; Do H; Weiss J; Byrne D; Chakrabarti A; Bosma T; ; Fellowes A; Dobrovic A; Fox SB
    Br J Cancer; 2014 Dec; 111(12):2351-60. PubMed ID: 25490678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers.
    Shaib WL; Zakka K; Staley C; Roberts A; Akce M; Wu C; Alese OB; El-Rayes BF
    Oncologist; 2020 May; 25(5):414-421. PubMed ID: 31784493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
    Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
    J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy.
    Olbryt M; Pigłowski W; Rajczykowski M; Pfeifer A; Student S; Fiszer-Kierzkowska A
    Target Oncol; 2020 Feb; 15(1):101-113. PubMed ID: 31980996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
    Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
    Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing the landscape of colorectal cancer using targeted deep sequencing.
    Lee CS; Song IH; Lee A; Kang J; Lee YS; Lee IK; Song YS; Lee SH
    Sci Rep; 2021 Apr; 11(1):8154. PubMed ID: 33854094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients.
    Chang YC; Chang JG; Liu TC; Lin CY; Yang SF; Ho CM; Chen WT; Chang YS
    World J Gastroenterol; 2016 Feb; 22(7):2314-25. PubMed ID: 26900293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity.
    Grünewald I; Vollbrecht C; Meinrath J; Meyer MF; Heukamp LC; Drebber U; Quaas A; Beutner D; Hüttenbrink KB; Wardelmann E; Hartmann W; Büttner R; Odenthal M; Stenner M
    Oncotarget; 2015 Jul; 6(20):18224-37. PubMed ID: 26053092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features.
    Alvarez K; Orellana P; Villarroel C; Contreras L; Kawachi H; Kobayashi M; Wielandt AM; De la Fuente M; Triviño JC; Kronberg U; Carvallo P; López-Köstner F
    Tumour Biol; 2017 Sep; 39(9):1010428317724517. PubMed ID: 28936923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
    Batta N; Pandey M
    World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic alterations in endometrial cancer by targeted next-generation sequencing.
    Chang YS; Huang HD; Yeh KT; Chang JG
    Exp Mol Pathol; 2016 Feb; 100(1):8-12. PubMed ID: 26626801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing.
    Zhao Y; He JY; Cui JZ; Meng ZQ; Zou YL; Guo XS; Chen X; Wang X; Yan LT; Han WX; Li C; Guo L; Bu H
    BMC Cancer; 2020 Jul; 20(1):690. PubMed ID: 32711494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
    Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
    Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.
    Peeters M; Oliner KS; Parker A; Siena S; Van Cutsem E; Huang J; Humblet Y; Van Laethem JL; André T; Wiezorek J; Reese D; Patterson SD
    Clin Cancer Res; 2013 Apr; 19(7):1902-12. PubMed ID: 23325582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
    Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
    F1000Res; 2019; 8():613. PubMed ID: 32612806
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary study of exon sequence in pneumoconiosis and pneumoconiosis complicated with lung cancer using high-throughput sequencing technology].
    Jiang MF; Li L; Wang Z; Zhang CL; Zhang H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Nov; 35(11):801-806. PubMed ID: 29316748
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
    Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
    Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic profiling in a homogeneous molecular subtype of non-small cell lung cancer: An effort to explore new drug targets.
    Veldore VH; Patil S; Satheesh CT; Shashidhara HP; Tejaswi R; Prabhudesai SA; Krishnamoorthy N; Hazarika D; Naik R; Rao RM; Ajai Kumar BS
    Indian J Cancer; 2015; 52(2):243-8. PubMed ID: 26853422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of extensive molecular profiling in advanced cancer patients.
    Cousin S; Grellety T; Toulmonde M; Auzanneau C; Khalifa E; Laizet Y; Tran K; Le Moulec S; Floquet A; Garbay D; Robert J; Hostein I; Soubeyran I; Italiano A
    J Hematol Oncol; 2017 Feb; 10(1):45. PubMed ID: 28179005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.